Moderna, IAVI to commence Phase I trial of mRNA HIV vaccine trial in Africa
The Phase I trial will analyse for safety and immunogenicity of the mRNA HIV vaccine antigen in African populations.
Middle East & Africa
Latest in
Middle East & Africa
Moderna’s Covid-19 vaccine trial in Africa receives support from CRO Emmes
The CRO will carry out data and statistical assessment to determine the relative risks of Covid-19 and severe disease.
The dynamics of clinical research in Africa: 2016–21
The level of clinical research in Africa remains very low in proportion to population size, despite an increase in trial…
By
Overcoming vaccine scepticism in Africa will reduce malaria burden
Malaria is a vector-borne disease caused by parasites of the genus Plasmodium. Malaria is transmitted through the bite of the…
By
Clinical trial data company Beaconcure eyes US expansion
Beaconcure’s platform Verify is designed to review clinical trial datasets and pinpoint inconsistencies.
By
NeuroSense previews Phase IIb trial plans for oral ALS drug
NeuroSense CEO Alon Ben-Noon reveals the target patient population and outcome measures of a planned Phase IIb ALS trial to…
By
Oramed ends subject enrolment in Phase II trial of oral insulin for NASH
The company anticipates reporting topline data from the trial in the second half of this year.
Major depressive disorder: where are the top clinical trial locations?
There is an emerging trend of specific sponsor types running MDD trials, as well as such studies embracing decentralisation.
By